LON:RENE

ReNeuron Group (RENE) Share Price, News & Analysis

ReNeuron Group logo

About ReNeuron Group Stock (LON:RENE)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
177,373 shs
Average Volume
578,249 shs
Market Capitalization
£1.93 million
P/E Ratio
N/A
Dividend Yield
0.76%
Price Target
N/A
Consensus Rating
N/A

Company Overview

ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized vesicles secreted by stem cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. The company was founded in 1997 and is headquartered in Pencoed, the United Kingdom.

Receive RENE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ReNeuron Group and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RENE Stock News Headlines

Top Trader Reveals Stunning Black Friday Deal
Others paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Trading's Thomas Wood calls it one of the firm's most powerful proprietary trading indicators, and says the company has never run a deal like this before. There are no strings attached, just a steep Black Friday discount on a tool built for traders.tc pixel
ReNeuron Group plc (LON:RENE): Is Breakeven Near?
See More Headlines

RENE Stock Analysis - Frequently Asked Questions

ReNeuron Group plc (LON:RENE) issued its quarterly earnings data on Monday, July, 20th. The company reported GBX (35.90) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of GBX (50.20) by GBX 14.30.

Based on aggregate information from My MarketBeat watchlists, some other companies that ReNeuron Group investors own include Lloyds Banking Group (LLOY), UK Oil & Gas (UKOG), NVIDIA (NVDA), ReNeuron Group (RNUGF), Seeing Machines (SEE), Active Energy Group (AEG) and Argo Blockchain (ARB).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Finance
Industry
Capital Markets
Sub-Industry
Asset Management & Custody Banks
Current Symbol
LON:RENE
CIK
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.09)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£5.07 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-106.77%
Return on Assets
-37.91%

Debt

Debt-to-Equity Ratio
14.25
Current Ratio
1.51
Quick Ratio
2.02

Sales & Book Value

Annual Sales
£783 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
0.61
Book Value
GBX 4 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
57,170,000
Free Float
N/A
Market Cap
£1.93 million
Optionable
Not Optionable
Beta
0.83
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

This page (LON:RENE) was last updated on 2/5/2024 by MarketBeat.com Staff.
From Our Partners